In conclusion, CYP2C19 transgenic mice show a motoric phenotype that shares some, but not all, ataxia‐like features and could be useful in the in vivo investigations of certain aspects of cerebellar function and development. The gene discussed is CYP2C19; the disease is Ataxia.